Oral mexiletine in high-risk patients after myocardial infarction.
D000284:Administration, Oral; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D002490:Central Nervous System / Q000187:drug effects; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008801:Mexiletine / Q000008:administration & dosage* / Q000009:adverse effects; D009203:Myocardial Infarction / Q000150:complications* / Q000401:mortality; D011437:Propylamines / Q000008:administration & dosage*; D012306:Risk
D011437:Propylamines; D008801:Mexiletine